The kit utilizes Illumina-compatible adapter sequences and has been validated on Illumina platforms.
Illumina plans $100M in cost cuts for 2025 after China bans its sequencers, impacting about 7% of its $4.3 billion sales. The firm lowered its 2025 adjusted EPS guidance to $4.50, at the low end ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback